• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非洲疟疾人群中对疑似疟原虫疫苗候选物的计算机分析。

In silico characterisation of putative Plasmodium falciparum vaccine candidates in African malaria populations.

机构信息

Medical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

First Technical University, Ibadan, Nigeria.

出版信息

Sci Rep. 2021 Aug 10;11(1):16215. doi: 10.1038/s41598-021-95442-4.

DOI:10.1038/s41598-021-95442-4
PMID:34376744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8355234/
Abstract

Genetic diversity of surface exposed and stage specific Plasmodium falciparum immunogenic proteins pose a major roadblock to developing an effective malaria vaccine with broad and long-lasting immunity. We conducted a prospective genetic analysis of candidate antigens (msp1, ama1, rh5, eba175, glurp, celtos, csp, lsa3, Pfsea, trap, conserved chrom3, hyp9, hyp10, phistb, surfin8.2, and surfin14.1) for malaria vaccine development on 2375 P. falciparum sequences from 16 African countries. We described signatures of balancing selection inferred from positive values of Tajima's D for all antigens across all populations except for glurp. This could be as a result of immune selection on these antigens as positive Tajima's D values mapped to regions with putative immune epitopes. A less diverse phistb antigen was characterised with a transmembrane domain, glycophosphatidyl anchors between the N and C- terminals, and surface epitopes that could be targets of immune recognition. This study demonstrates the value of population genetic and immunoinformatic analysis for identifying and characterising new putative vaccine candidates towards improving strain transcending immunity, and vaccine efficacy across all endemic populations.

摘要

表面暴露和阶段特异性疟原虫免疫原性蛋白的遗传多样性对开发具有广泛和持久免疫力的有效疟疾疫苗构成了重大障碍。我们对来自 16 个非洲国家的 2375 个疟原虫序列进行了候选抗原(msp1、ama1、rh5、eba175、glurp、celtos、csp、lsa3、Pfsea、trap、保守 chrom3、hyp9、hyp10、phistb、surfin8.2 和 surfin14.1)的前瞻性遗传分析,以用于疟疾疫苗的开发。除了 glurp 之外,我们描述了所有抗原在所有人群中都存在正 Tajima's D 值所推断出的平衡选择特征。这可能是由于这些抗原受到免疫选择的影响,因为正 Tajima's D 值映射到具有潜在免疫表位的区域。phistb 抗原的多样性较低,具有跨膜结构域、N 和 C 末端之间的糖磷脂锚,以及可能成为免疫识别目标的表面表位。这项研究表明,群体遗传和免疫信息学分析对于识别和表征新的潜在疫苗候选物具有重要价值,可以提高跨越所有流行人群的菌株免疫和疫苗效力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/6c532f737ba3/41598_2021_95442_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/05818b5fcc3e/41598_2021_95442_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/aefc0729ac4a/41598_2021_95442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/ada1c3b96737/41598_2021_95442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/f47dc760476f/41598_2021_95442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/6c532f737ba3/41598_2021_95442_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/05818b5fcc3e/41598_2021_95442_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/aefc0729ac4a/41598_2021_95442_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/ada1c3b96737/41598_2021_95442_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/f47dc760476f/41598_2021_95442_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9d0/8355234/6c532f737ba3/41598_2021_95442_Fig5_HTML.jpg

相似文献

1
In silico characterisation of putative Plasmodium falciparum vaccine candidates in African malaria populations.在非洲疟疾人群中对疑似疟原虫疫苗候选物的计算机分析。
Sci Rep. 2021 Aug 10;11(1):16215. doi: 10.1038/s41598-021-95442-4.
2
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum.多样性和选择分析将阻断传播的抗原确定为恶性疟原虫的最佳疫苗候选物。
EBioMedicine. 2024 Aug;106:105227. doi: 10.1016/j.ebiom.2024.105227. Epub 2024 Jul 16.
3
Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin.人群内疟原虫疫苗候选抗原的遗传多样性揭示了与中非起源地的地理距离。
Vaccine. 2013 Feb 18;31(9):1334-9. doi: 10.1016/j.vaccine.2012.12.039. Epub 2013 Jan 4.
4
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.三抗原恶性疟原虫 DNA 初免-腺病毒增强疟疾疫苗方案优于两抗原方案,可预防健康无疟疾史成年人的疟疾感染。
PLoS One. 2021 Sep 8;16(9):e0256980. doi: 10.1371/journal.pone.0256980. eCollection 2021.
5
Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations.印度恶性疟原虫群体中顶端膜抗原1第一结构域的序列多样性与自然选择
Malar J. 2007 Nov 22;6:154. doi: 10.1186/1475-2875-6-154.
6
Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.对恶性疟原虫MSP3和GLURP(R0)抗原的天然抗体反应与生活在加纳中部地区疟疾患者的低寄生虫密度相关。
Parasit Vectors. 2017 Aug 23;10(1):395. doi: 10.1186/s13071-017-2338-7.
7
Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.双等位基因血期疟疾病毒载体疫苗免疫后对免疫干扰、拮抗和转移的评估及对照性疟疾感染。
J Immunol. 2013 Feb 1;190(3):1135-47. doi: 10.4049/jimmunol.1201455. Epub 2013 Jan 4.
8
Estimation of PfRh5-based vaccine efficacy in asymptomatic patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.利用基因和抗原性变异筛查评估坦桑尼亚高流行地区无症状患者中基于PfRh5的疫苗效力。
Front Immunol. 2024 Nov 18;15:1495513. doi: 10.3389/fimmu.2024.1495513. eCollection 2024.
9
Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.尼日利亚拉各斯人群疟原虫红细胞结合蛋白同源物 5 候选疫苗中的遗传多态性。
Malar J. 2020 Jan 6;19(1):6. doi: 10.1186/s12936-019-3096-0.
10
Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.通过增强疟疾候选疫苗顶膜抗原 1 上保守表位的免疫原性来克服抗原多样性。
PLoS Pathog. 2013;9(12):e1003840. doi: 10.1371/journal.ppat.1003840. Epub 2013 Dec 26.

引用本文的文献

1
Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal.来自塞内加尔临床分离株中恶性疟原虫Pf41疫苗候选株的遗传多样性和自然选择
Sci Rep. 2025 May 13;15(1):16516. doi: 10.1038/s41598-025-00784-y.
2
Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions.疟疾疫苗接种的当前进展:关于实施、挑战及未来方向的简要综述
Clin Pharmacol. 2025 Apr 1;17:29-47. doi: 10.2147/CPAA.S513282. eCollection 2025.
3
Poly-basic peptides and polymers as new drug candidates against Plasmodium falciparum.

本文引用的文献

1
Global Repertoire of Human Antibodies Against RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population.在疟疾暴露人群中针对 RIFINs、SURFINs 和 STEVORs 的人源抗体的全球抗体库。
Front Immunol. 2020 May 12;11:893. doi: 10.3389/fimmu.2020.00893. eCollection 2020.
2
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.在全生物体疟原虫疫苗试验中使用的菌株在基因组结构、序列和免疫原性潜力方面存在差异。
Genome Med. 2020 Jan 8;12(1):6. doi: 10.1186/s13073-019-0708-9.
3
Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines.
多碱基肽和聚合物作为抗疟原虫 falciparum 的新药候选物。
Malar J. 2024 Aug 1;23(1):227. doi: 10.1186/s12936-024-05056-0.
4
Genetic polymorphism and evidence of signatures of selection in the Plasmodium falciparum circumsporozoite protein gene in Tanzanian regions with different malaria endemicity.在疟疾流行程度不同的坦桑尼亚地区,对疟原虫环子孢子蛋白基因的遗传多态性和选择信号的证据进行研究。
Malar J. 2024 May 8;23(1):139. doi: 10.1186/s12936-024-04974-3.
5
Genetic polymorphism and evidence of signatures of selection in the circumsporozoite protein gene in Tanzanian regions with different malaria endemicity.坦桑尼亚不同疟疾流行程度地区环子孢子蛋白基因的遗传多态性及选择特征证据
medRxiv. 2024 Jan 23:2024.01.23.24301587. doi: 10.1101/2024.01.23.24301587.
6
Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.部署下一代测序和 CRISPR-Cas 系统以支持疟疾控制和消除的诊断和监测的潜在机遇和挑战:在非洲。
Front Cell Infect Microbiol. 2022 Jul 13;12:757844. doi: 10.3389/fcimb.2022.757844. eCollection 2022.
7
An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes.疟疾红细胞前期阶段抗原的计算机模拟分析:解读全球遗传数据以提出疫苗候选变体和表位
Microorganisms. 2022 May 25;10(6):1090. doi: 10.3390/microorganisms10061090.
血液期抗疟疫苗:正在进行的临床试验分析及与合成疫苗相关的新观点
Front Microbiol. 2019 Dec 3;10:2712. doi: 10.3389/fmicb.2019.02712. eCollection 2019.
4
High Plasmodium falciparum genetic diversity and temporal stability despite control efforts in high transmission settings along the international border between Zambia and the Democratic Republic of the Congo.尽管在赞比亚和刚果民主共和国之间的国际边境高传播地区进行了控制工作,但恶性疟原虫的遗传多样性仍然很高,且具有时间稳定性。
Malar J. 2019 Dec 4;18(1):400. doi: 10.1186/s12936-019-3023-4.
5
Major subpopulations of in sub-Saharan Africa.撒哈拉以南非洲的 主要亚群。
Science. 2019 Aug 23;365(6455):813-816. doi: 10.1126/science.aav5427.
6
Challenges and strategies for developing efficacious and long-lasting malaria vaccines.开发有效和持久的疟疾疫苗面临的挑战和策略。
Sci Transl Med. 2019 Jan 9;11(474). doi: 10.1126/scitranslmed.aau1458.
7
Maternally-derived Antibodies to Schizont Egress Antigen-1 and Protection of Infants From Severe Malaria.母源来源的裂殖子外排抗原 1 抗体及对婴儿重症疟疾的保护作用。
Clin Infect Dis. 2019 May 2;68(10):1718-1724. doi: 10.1093/cid/ciy728.
8
Malaria Vaccines: Recent Advances and New Horizons.疟疾疫苗:最新进展与新前景。
Cell Host Microbe. 2018 Jul 11;24(1):43-56. doi: 10.1016/j.chom.2018.06.008.
9
Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate Reticulocyte-Binding Protein Homologue-5 in Kalifabougou, Mali.在马里加利法布古,疟疾候选疫苗原虫结合蛋白同源物-5 的多态性的范围和动态。
Am J Trop Med Hyg. 2018 Jul;99(1):43-50. doi: 10.4269/ajtmh.17-0737. Epub 2018 May 24.
10
RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally.在南部和中部非洲以及全球的疟原虫分离株中观察到 RTS,S/AS01 疟疾疫苗不匹配。
Sci Rep. 2018 Apr 26;8(1):6622. doi: 10.1038/s41598-018-24585-8.